Sildenafil versus Low Molecular Weight Heparin in fetal Growth Restriction Treatment: RCT

Abstract

Abstract In conclusion, fetal growth restriction (FGR) remains one of the major challenges in the maternity care as well as one of the major causes of perinatal morbidity and mortality. In the present study; we have presented data suggesting that, sildenafil and LMWH treatment may offer a new opportunity to improve perinatal outcomes for women whose pregnancies are complicated by FGR with improvement of the fetal growth parameters and reduction of NICU admissions. However, sildenafil carries more side effects despite tolerated. The implications of sildenafil for increasing the fetal weight in FGR pregnancies showed significantly lower results than LMWH and have to be considered for future studies.